Example: Heart Attack
Clinical Trials on Coxsackievirus Infections
Total 0 results
We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
Medical Conditions
- COVID-19
- Alcohol Consumption, Youth
- Cardiometabolic Disease
- Congestive Heart Failure Exacerbation
- Early Childhood Development in HIV-Exposed Children
- Hypodermoclysis
- Intractable Obesity
- Laser Thermotherapy, Stress Urinary Incontinence
- Mixed Oligoastrocytomas
- PFIC2
- Peripheral Primitive Neuroectodermal Tumor of Bone
- Portosystemic Shunt
- Spasticity-ataxia-gait Anomalies Syndrome
- Treatment of PHN
- View Full List
Sponsors and Collaborators
- American Cancer Society - Asian Initiatives
- EUSA SAS
- Enzymotec
- Foresee Pharmaceuticals Co., Ltd.
- Gabr, Hala , M.D. M.Sc.
- Global Emerging Infections Surveillance and Response System
- Inflamax Research Incorporated
- Millennium Institute for Research in Depression and Personality (MIDAP)
- Oklahoma City VA Medical Center
- Retina-Vitreous Associates Medical Group
- Rheoscience A/S
- The Ministry of Health and Prevention, Denmark
- Zhu Ji
- View Full List
Drug Interventions
- Argon fulguration
- Citalopram + Pipamperone
- Dextrose Oral Tablet, Chewable
- Ethiodized Oil
- Hyperglycemic clamp with placebo infusion
- JNJ-40411813 50 mg
- Norepinephrine: 1mcg/kg
- OC-02
- Permethrin Foam 5%
- Treatment BC
- epidoxorubicine, docetaxel, cyclophosphamide
- travoprost, latanoprost, or bimatoprost
- vosaroxin
- View Full List
Conditions
Rare Diseases
Drug Interventions
Dietary Supplements
Sponsor/Collaborators
Locations